炎症相关骨质疏松症的发病机制

被引:50
作者
夏婷
李双庆
机构
[1] 四川大学华西医院金卡病房(全科病房)
关键词
骨质疏松症; 炎症;
D O I
暂无
中图分类号
R580 [];
学科分类号
摘要
炎症相关骨质疏松症是指炎症特别是系统性炎症引起的骨量减少、骨质破坏。近期的研究发现多种炎性疾病与骨质疏松症相关,炎症引起骨质疏松的发病涉及环氧化酶-2(COX-2)、白细胞介素、肿瘤坏死因子α(TNF-alpha)、RANKL/RANK/OPG系统、C反应蛋白、一氧化氮(nitric oxide)、端粒酶等,发病机制的研究促进了denosumab等骨质疏松新药的研发。
引用
收藏
页码:117 / 120
页数:4
相关论文
共 11 条
[1]
Telomerase-Deficient Mice Exhibit Bone Loss Owing to Defects in Osteoblasts and Increased Osteoclastogenesis by Inflammatory Microenvironment [J].
Saeed, Hamid ;
Abdallah, Basem M. ;
Ditzel, Nicholas ;
Catala-Lehnen, Philip ;
Qiu, Weimin ;
Amling, Michael ;
Kassem, Moustapha .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (07) :1494-1505
[2]
Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial [J].
Miller, Paul D. ;
Wagman, Rachel B. ;
Peacock, Munro ;
Lewiecki, E. Michael ;
Bolognese, Michael A. ;
Weinstein, Richard L. ;
Ding, Beiying ;
Martin, Javier San ;
McClung, Michael R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (02) :394-402
[3]
Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss.[J].Vincent Goeb;Trouvin Anne-Priscille.Clinical Interventions in Aging.2010, defa
[4]
Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE 2 synthesis.[J].Tsai-Pei Hsieh;Shiow-Yunn Sheu;Jui-Sheng Sun;Ming-Hong Chen.Phytomedicine.2010, 2
[5]
Effect of IL‐1β; PGE<sub>2</sub>; and TGF‐β1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts.[J].SusanaJurado;NataliaGarcia‐Giralt;AdolfoDíez‐Pérez;PedroEsbrit;GuyYoskovitz;LídiaAgueda;RoserUrreizti;LluísPérez‐Edo;GuillemSaló;LeonardoMellibovsky;SusanaBalcells;DanielGrinberg;XavierNogués.J. Cell. Biochem..2010, 2
[6]
Evidence for a Pathogenic Role of Nitric Oxide in Inflammation‐Induced Osteoporosis.[J].Katharine E.Armour;Robert J.Van 'T Hof;Peter S.Grabowski;David M.Reid;Stuart H.Ralston.J Bone Miner Res.2009, 12
[7]
Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis [J].
D'Amelio, Patrizia ;
Grimaldi, Anastasia ;
Di Bella, Stefania ;
Brianza, Stefano Z. M. ;
Cristofaro, Maria Angela ;
Tamone, Cristina ;
Giribaldi, Giuliana ;
Ulliers, Daniela ;
Pescarmona, Gian P. ;
Isaia, Giancarlo .
BONE, 2008, 43 (01) :92-100
[8]
The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study [J].
Richards, J. B. ;
Joseph, L. ;
Schwartzman, K. ;
Kreiger, N. ;
Tenenhouse, A. ;
Goltzman, D. .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (09) :1410-1419
[9]
Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis [J].
Koh, JM ;
Khang, YH ;
Jung, CH ;
Bae, S ;
Kim, DJ ;
Chung, YE ;
Kim, GS .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (10) :1263-1271
[10]
Increased expression of receptor activator of NF-κB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients [J].
Franchimont, N ;
Reenaers, C ;
Lambert, C ;
Belaiche, J ;
Bours, V ;
Malaise, M ;
Delvenne, P ;
Louis, E .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03) :491-498